PRS38 - COST-CONSEQUENCE ANALYSIS OF FLUTICASONE FUROATE/VILANTEROL FOR ASTHMA MANAGEMENT IN SPAIN- AN ANALYSIS BASED ON THE SALFORD LUNG STUDY IN ASTHMA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2432
https://www.valueinhealthjournal.com/article/S1098-3015(18)35734-6/fulltext
Title :
PRS38 - COST-CONSEQUENCE ANALYSIS OF FLUTICASONE FUROATE/VILANTEROL FOR ASTHMA MANAGEMENT IN SPAIN- AN ANALYSIS BASED ON THE SALFORD LUNG STUDY IN ASTHMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35734-6&doi=10.1016/j.jval.2018.09.2432
First page :
Section Title :
Open access? :
No
Section Order :
1790